+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Medical Simulation Market by Product & Service, Fidelity, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 245 Pages
  • November 2021
  • Region: Global
  • Allied Market Research
  • ID: 5157260
The global medical simulation market was valued at $1,687.50 million in 2020, and is estimated to reach $6,689.60 million by 2030, growing at a CAGR of 14.7% from 2021 to 2030. Medical simulation is a virtual duplication of in situ activities or phenomenon, representing functions and properties of a selective real abstract or process. It is a branch of simulation relating to teaching and training in various medical professions. Simulations can take place in the classroom, in situational settings, or in specially designed venues for simulation exercise. It can include simulated human patients; artificial human, or a combination of the two, educational papers with comprehensive simulated animations, casualty assessment in national security and war scenarios, emergency response, and holographic simulation to support virtual health activities.



Medical simulation also known as healthcare simulation or clinical simulation. It is used to train healthcare professionals using advanced healthcare technologies. It is a contemporary technique that every healthcare practitioner will require but will not always be able to partake in during real-life patient care. Its primary goal was to teach medical professionals to decrease errors in surgery, medication, crisis response, and general practice. It is currently utilized to teach students in anatomy, physiology, and communication during their schooling, when combined with debriefing approaches.

Medical simulators are rapidly becoming a standard component of the educational services provided to medical students, residents, fellows, nursing staff, ancillary health care workers, and practicing physicians all around the world. The rising demand for evidence based treatment services and the decrease in the amount of hours that residents may work each week are two of the reasons for this acceptance. To achieve time, cost, and resource efficiencies that enable successful training, more medical programs are being integrated in traditional classroom and hands-on instruction with the use of computer based medical simulators.

Increase in the use of medical simulation is mainly due rise in use of simulation in healthcare; increase in deaths, owing to medical errors; and necessity to improve patient safety outcomes. According to the World Health Organization (WHO) in 2019, patient safety is one of the serious global public health concern and there is about 1 in 300 chance of a patient being harmed during health care. In addition, it is estimated that there are about 421 million hospitalizations in the world annually, and approximately 42.7 million adverse events or errors occur in patients during these hospitalizations and is further estimated that patient harm is the 14th leading cause of morbidity and mortality across the world. Moreover, inaccurate or delayed diagnoses affect all settings of care and harm an unacceptable number of patients and research shows that at least 5% of adults in the U.S. experience a diagnostic error each year in outpatient settings. Recent postmortem examination research spanning decades has shown that diagnostic errors contribute to approximately 10% of patient deaths in the U.S.

Moreover, benefits such as training of complex as well as normal cases to professionals and technological advancements in the medical field further increases demand for medical simulation. Limited access to patients during medical training, increasing demand for minimally invasive treatments, and rise in demand for virtual training interaction due to the COVID-19 pandemic has further propelled the growth of the medical simulator market.

The advancement of surgical tools for research and development has raised public awareness of minimally invasive surgical methods. Minimally invasive treatments need specialized psychomotor abilities. Simulation offers the necessary tools for mastering these minimally invasive treatments. In addition, augmented reality is utilized for training and teaching and AR-based apps are utilized to give efficient treatment. Thus, surge in demand for minimally invasive surgical techniques is expected to significantly boost the healthcare simulation market. However, high installation cost and lack of complete real situation restrains the market growth.

The medical simulation market is segmented on the basis of product & service, fidelity, end user, and region. On the basis of product & service, it is divided into model-based simulation, web-based simulation, and simulation training services. The model-based simulation segment is further classified into patient simulation, surgical simulation, and ultrasound simulation. Moreover, patient simulation is segmented into task trainer simulation, manikin-based simulators, hybrid manikin-based simulation (with AR) and standardized patient simulators. Surgical simulation is divided in laparoscopic surgical simulators, arthroscopic surgical simulators, cardiovascular simulators, gynecology simulators, orthopedic simulators, spine simulators, endovascular simulators and others. Furthermore, ultrasound simulation is segmented into anesthesia, cardiology, emergency medicine, intensive care unit, obstetrics & gynecology, radiology and others.

In addition, the web-based simulation segment is classified into simulation software, performance-recording software, virtual tutors and learning management software. The simulation training services segment comprise vendor-based training services, custom consulting services, and educational society.

On the basis of fidelity, the market is classified into low fidelity, medium fidelity, and high fidelity simulators. By end user, it is divided into academic institutions, hospitals, and military organizations.

The major players profiled in the report are CAE, Inc., Gaumard Scientific Company, Inc., Intelligent Ultrasound Group Plc., Kyoto Kagaku Co. Ltd., Laerdal Medical AS, Limbs and Things, Ltd., Mentice AB, Operative Experience, Inc., Simulab Corporation, and VirtaMed AG.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global medical simulation market to identify the prevailing opportunities.
  • This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Region & country-wise analysis is provided to understand the market trends and dynamics.

KEY MARKET SEGMENTS


By Product & Services

  • Model-based Simulation
  • Patient Simulation
  • Task Trainer Simulation
  • Manikin-based Simulation
  • Adult
  • Pediatric
  • Neonatal
  • Hybrid Manikin-based simulation (with AR)
  • Standardized Patient Simulation
  • Surgical Simulation
  • Laparoscopic Surgical Simulators
  • Arthroscopic Surgical Simulators
  • Cardiovascular Simulators
  • Gynecology Simulators
  • Orthopedic Simulators
  • Spine Simulators
  • Endovascular Simulators
  • Others
  • Ultrasound Simulation
  • Anesthesia
  • Cardiology
  • Emergency Medicine
  • Intensive Care Unit
  • OB/GYN
  • Radiology
  • Others (Urology, General Nursing, Pediatrics)
  • Web-based Simulation
  • Simulation Software
  • Performance Recording Software
  • Virtual Tutors
  • Learning Management Software
  • Simulation Training Services
  • Vendor-based Training
  • Custom Consulting Services
  • Educational Societies

By Fidelity

  • Low-fidelity
  • Medium-fidelity
  • High-fidelity

By End User

  • Academic Institutions
  • Hospitals
  • Military Organizations

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

KEY MARKET PLAYERS

  • CAE, Inc.
  • Gaumard Scientific Company, Inc.
  • Intelligent Ultrasound Group Plc.
  • Kyoto Kagaku Co. Ltd.
  • Laerdal Medical AS
  • Limbs and Things, Ltd.
  • Mentice AB
  • Operative Experience, Inc.
  • Simulab Corporation
  • VirtaMed AG

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profile in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in use of virtual and augmented reality
3.5.1.2. Assured improvement in patient safety outcomes
3.5.1.3. Benefits of medical simulation
3.5.1.4. Technological advancements in medical field
3.5.1.5. Increase in demand for virtual training
3.5.2. Restraints
3.5.2.1. High cost for setting up simulators
3.5.2.2. Limitation to imitate a complete real situation
3.5.3. Opportunity
3.5.3.1. Lucrative opportunities in emerging markets
3.5.4. Impact analysis
3.6. Impact analysis of COVID-19 on the medical simulation market
CHAPTER 4: GLOBAL MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE
4.1. Overview
4.1.1. Market size and forecast
4.2. Model-based simulation
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.4. Market size and forecast, by type
4.2.4.1. Patient simulation
4.2.4.1.1. Market size and forecast
4.2.4.1.2. Manikin-based simulation
4.2.4.2. Surgical simulation
4.2.4.2.1. Market size and forecast
4.2.4.3. Ultrasound simulation
4.2.4.3.1. Market size and forecast
4.3. Web-based simulation
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.3.4. Market size and forecast, by type
4.3.4.1. Simulation software
4.3.4.1.1. Market size and forecast
4.3.4.2. Performance recording software
4.3.4.2.1. Market size and forecast
4.3.4.3. Virtual tutors
4.3.4.3.1. Market size and forecast
4.3.4.4. Learning management software
4.3.4.4.1. Market size and forecast
4.4. Simulation training services
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.4.4. Market size and forecast, by type
4.4.4.1. Vendor-based training
4.4.4.1.1. Market size and forecast
4.4.4.2. Custom consulting services
4.4.4.2.1. Market size and forecast
4.4.4.3. Educational societies
4.4.4.3.1. Market size and forecast
CHAPTER 5: GLOBAL MEDICAL SIMULATION MARKET, BY FIDELITY
5.1. Overview
5.1.1. Market size and forecast
5.2. Low-fidelity
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Medium-fidelity
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. High-fidelity
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
CHAPTER 6: GLOBAL MEDICAL SIMULATION MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Academic institutions
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Hospitals
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Military organizations
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7: MEDICAL SIMULATION MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America medical simulation market, by product & service
7.2.3. North America medical simulation market, by fidelity
7.2.4. North America medical simulation market, by end user
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. U.S. medical simulation market, by product & service
7.2.5.1.2. U.S. medical simulation market, by fidelity
7.2.5.1.3. U.S. medical simulation market, by end user
7.2.5.2. Canada
7.2.5.2.1. Canada medical simulation market, by product & service
7.2.5.2.2. Canada medical simulation market, by fidelity
7.2.5.2.3. Canada medical simulation market, by end user
7.2.5.3. Mexico
7.2.5.3.1. Mexico medical simulation market, by product & service
7.2.5.3.2. Mexico medical simulation market, by fidelity
7.2.5.3.3. Mexico medical simulation market, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe medical simulation market, by product & service
7.3.3. Europe medical simulation market, by fidelity
7.3.4. Europe medical simulation market, by end user
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Germany medical simulation market, by product & service
7.3.5.1.2. Germany medical simulation market, by fidelity
7.3.5.1.3. Germany medical simulation market, by end user
7.3.5.2. France
7.3.5.2.1. France medical simulation market, by product & service
7.3.5.2.2. France medical simulation market, by fidelity
7.3.5.2.3. France medical simulation market, by end user
7.3.5.3. UK
7.3.5.3.1. UK medical simulation market, by product & service
7.3.5.3.2. UK medical simulation market, by fidelity
7.3.5.3.3. UK medical simulation market, by end user
7.3.5.4. Italy
7.3.5.4.1. Italy medical simulation market, by product & service
7.3.5.4.2. Italy medical simulation market, by fidelity
7.3.5.4.3. Italy medical simulation market, by end user
7.3.5.5. Spain
7.3.5.5.1. Spain medical simulation market, by product & service
7.3.5.5.2. Spain medical simulation market, by fidelity
7.3.5.5.3. Spain medical simulation market, by end user
7.3.5.6. Rest of Europe
7.3.5.6.1. Rest of Europe medical simulation market, by product & service
7.3.5.6.2. Rest of Europe medical simulation market, by fidelity
7.3.5.6.3. Rest of Europe medical simulation market, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific medical simulation market, by product & service
7.4.3. Asia-Pacific medical simulation market, by fidelity
7.4.4. Asia-Pacific medical simulation market, by end user
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Japan medical simulation market, by product & service
7.4.5.1.2. Japan medical simulation market, by fidelity
7.4.5.1.3. Japan medical simulation market, by end user
7.4.5.2. China
7.4.5.2.1. China medical simulation market, by product & service
7.4.5.2.2. China medical simulation market, by fidelity
7.4.5.2.3. China medical simulation market, by end user
7.4.5.3. Australia
7.4.5.3.1. Australia medical simulation market, by product & service
7.4.5.3.2. Australia medical simulation market, by fidelity
7.4.5.3.3. Australia medical simulation market, by end user
7.4.5.4. India
7.4.5.4.1. India medical simulation market, by product & service
7.4.5.4.2. India medical simulation market, by fidelity
7.4.5.4.3. India medical simulation market, by end user
7.4.5.5. Rest of Asia-Pacific
7.4.5.5.1. Rest of Asia-Pacific medical simulation market, by product & service
7.4.5.5.2. Rest of Asia-Pacific medical simulation market, by fidelity
7.4.5.5.3. Rest of Asia-Pacific medical simulation market, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA medical simulation market, by product & service
7.5.3. LAMEA medical simulation market, by fidelity
7.5.4. LAMEA medical simulation market, by end user
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Brazil medical simulation market, by product & service
7.5.5.1.2. Brazil medical simulation market, by fidelity
7.5.5.1.3. Brazil medical simulation market, by end user
7.5.5.2. Saudi Arabia
7.5.5.2.1. Saudi Arabia medical simulation market, by product & service
7.5.5.2.2. Saudi Arabia medical simulation market, by fidelity
7.5.5.2.3. Saudi Arabia medical simulation market, by end user
7.5.5.3. South Africa
7.5.5.3.1. South Africa medical simulation market, by product & service
7.5.5.3.2. South Africa medical simulation market, by fidelity
7.5.5.3.3. South Africa medical simulation market, by end user
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Rest of LAMEA medical simulation market, by product & service
7.5.5.4.2. Rest of LAMEA medical simulation market, by fidelity
7.5.5.4.3. Rest of LAMEA medical simulation market, by end user
CHAPTER 8: COMPANY PROFILES
8.1. CAE INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. GAUMARD SCIENTIFIC COMPANY
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Key strategic moves and developments
8.3. INTELLIGENT ULTRASOUND GROUP PLC.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. KYOTO KAGAKU CO. LTD.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.5. LAERDAL MEDICAL AS
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Key strategic moves and developments
8.6. LIMBS AND THINGS LTD.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Key strategic moves and developments
8.7. MENTICE AB
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. OPERATIVE EXPERIENCE, INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segment
8.8.4. Product portfolio
8.8.5. Key strategic moves and developments
8.9. SIMULAB CORPORATION
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Key strategic moves and developments
8.10. VIRTAMED AG
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segment
8.10.4. Product portfolio
8.10.5. Key strategic moves and developments
List of Tables
TABLE 01. GLOBAL MEDICAL SIMULATION MARKET, BY PRODUCTS & SERVICES, 2020–2030 ($MILLION)
TABLE 02. MEDICAL SIMULATION MARKET FOR MODEL-BASED SIMULATION MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03. GLOBAL MODEL-BASED SIMULATION MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 04. GLOBAL PATIENT SIMULATION MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 05. GLOBAL MANIKIN-BASED SIMULATION MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 06. GLOBAL SURGICAL SIMULATION MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 07. GLOBAL ULTRASOUND SIMULATION MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 08. MEDICAL SIMULATION MARKET FOR WEB-BASED SIMULATION MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 09. GLOBAL WEB-BASED MEDICAL SIMULATION MARKET, BY TYPE, 2020–2030($MILLION)
TABLE 10. GLOBAL SIMULATION SOFTWARE MARKET, 2020–2030 ($MILLION)
TABLE 11. GLOBAL PERFORMANCE RECORDING SOFTWARE MARKET, 2020–2030 ($MILLION)
TABLE 12. GLOBAL VIRTUAL TUTORS MARKET, 2020–2030 ($MILLION)
TABLE 13. GLOBAL LEARNING MANAGEMENT SOFTWARE MARKET, 2020–2030 ($MILLION)
TABLE 14. MEDICAL SIMULATION MARKET FOR SIMULATION TRAINING SERVICES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 15. GLOBAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 16. GLOBAL VENDOR-BASED TRAINING MARKET, 2020–2030 ($MILLION)
TABLE 17. GLOBAL CUSTOM CONSULTING SERVICES MARKET, 2020–2030 ($MILLION)
TABLE 18. GLOBAL EDUCATIONAL SOCIETIES MARKET, 2020–2030 ($MILLION)
TABLE 19. GLOBAL MEDICAL SIMULATION MARKET, BY FIDELITY, 2020–2030 ($MILLION)
TABLE 20. GLOBAL MEDICAL SIMULATION MARKET FOR LOW-FIDELITY, BY REGION, 2020–2030($MILLION)
TABLE 21. GLOBAL MEDICAL SIMULATION MARKET FOR MEDIUM-FIDELITY, BY REGION, 2020–2030($MILLION)
TABLE 22. GLOBAL MEDICAL SIMULATION MARKET FOR HIGH-FIDELITY, BY REGION, 2020–2030 ($MILLION)
TABLE 23. GLOBAL MEDICAL SIMULATION MARKET, BY END USER 2020–2030 ($MILLION)
TABLE 24. GLOBAL MEDICAL SIMULATION MARKET FOR ACADEMIC INSTITUTIONS, BY REGION, 2020–2030 ($MILLION)
TABLE 25. GLOBAL MEDICAL SIMULATION MARKET FOR HOSPITALS, BY REGION, 2020–2030($MILLION)
TABLE 26. GLOBAL MEDICAL SIMULATION MARKET FOR MILITARY ORGANIZATIONS, BY REGION, 2020–2030($MILLION)
TABLE 27. MEDICAL SIMULATION MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 28. NORTH AMERICA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 29. NORTH AMERICA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 30. NORTH AMERICA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 31. NORTH AMERICA MEDICAL SIMULATION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 32. U.S. MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 33. U.S. MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 34. U.S. MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 35. CANADA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 36. CANADA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 37. CANADA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 38. MEXICO MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 39. MEXICO MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 40. MEXICO MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 41. EUROPE MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 42. EUROPE MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 43. EUROPE MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 44. EUROPE MEDICAL SIMULATION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 45. GERMANY MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 46. GERMANY MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 47. GERMANY MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 48. FRANCE MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 49. FRANCE MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 50. FRANCE MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 51. UK MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 52. UK MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 53. UK MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 54. ITALY MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 55. ITALY MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 56. ITALY MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 57. SPAIN MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 58. SPAIN MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 59. SPAIN MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 60. REST OF EUROPE MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 61. REST OF EUROPE MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 62. REST OF EUROPE MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 63. ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 64. ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 65. ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 66. ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 67. JAPAN MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 68. JAPAN MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 69. JAPAN MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 70. CHINA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 71. CHINA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 72. CHINA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 73. AUSTRALIA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 74. AUSTRALIA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 75. AUSTRALIA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 76. INDIA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 77. INDIA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 78. INDIA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 79. REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 80. REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 81. REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 82. LAMEA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 83. LAMEA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 84. LAMEA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 85. LAMEA MEDICAL SIMULATION MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 86. BRAZIL MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 87. BRAZIL MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 88. BRAZIL MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 89. SAUDI ARABIA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 90. SAUDI ARABIA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 91. SAUDI ARABIA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 92. SOUTH AFRICA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 93. SOUTH AFRICA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 94. SOUTH AFRICA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 95. REST OF LAMEA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020-2030 ($MILLION)
TABLE 96. REST OF LAMEA MEDICAL SIMULATION MARKET, BY FIDELITY, 2020-2030 ($MILLION)
TABLE 97. REST OF LAMEA MEDICAL SIMULATION MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 98. CAE: COMPANY SNAPSHOT
TABLE 99. CAE: OPERATING SEGMENTS
TABLE 100. CAE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 101. CAE: KEY DEVELOPMENTS
TABLE 102. GAUMARD: COMPANY SNAPSHOT
TABLE 103. GAUMARD: OPERATING SEGMENTS
TABLE 104. GAUMARD: PRODUCT PORTFOLIO
TABLE 105. GAUMARD: KEY DEVELOPMENTS
TABLE 106. INTELLIGENT: COMPANY SNAPSHOT
TABLE 107. INTELLIGENT: OPERATING SEGMENTS
TABLE 108. INTELLIEGENT: PRODUCT PORTFOLIO
TABLE 109. INTELLIGENT: KEY DEVELOPMENTS
TABLE 110. KYOTO KAGAKU: COMPANY SNAPSHOT
TABLE 111. KYOTO KAGAKU: OPERATING SEGMENTS
TABLE 112. KYOTO KAGAKU: PRODUCT PORTFOLIO
TABLE 113. LAERDAL: COMPANY SNAPSHOT
TABLE 114. LAERDAL: OPERATING SEGMENTS
TABLE 115. LAERDAL: PRODUCT PORTFOLIO
TABLE 116. LAERDAL: KEY DEVELOPMENTS
TABLE 117. LIMBS & THINGS: COMPANY SNAPSHOT
TABLE 118. LIMBS & THINGS: OPERATING SEGMENTS
TABLE 119. LIMBS & THINGS: PRODUCT PORTFOLIO
TABLE 120. LIMBS & THINGS: KEY DEVELOPMENTS
TABLE 121. MENTICE: COMPANY SNAPSHOT
TABLE 122. MENTICE: OPERATING SEGMENTS
TABLE 123. MENTICE: PRODUCT PORTFOLIO
TABLE 124. MENTICE: KEY DEVELOPMENTS
TABLE 125. OPERATIVE: COMPANY SNAPSHOT
TABLE 126. OPERATIVE: OPERATING SEGMENTS
TABLE 127. OPERATIVE: PRODUCT PORTFOLIO
TABLE 128. OPERATIVE: KEY DEVELOPMENTS
TABLE 129. SIMULAB: COMPANY SNAPSHOT
TABLE 130. SIMULAB: OPERATING SEGMENTS
TABLE 131. SIMULAB: PRODUCT PORTFOLIO
TABLE 132. SIMULAB: KEY DEVELOPMENTS
TABLE 133. VIRTAMED: COMPANY SNAPSHOT
TABLE 134. VIRTAMED: OPERATING SEGMENTS
TABLE 135. VIRTAMED: PRODUCT PORTFOLIO
TABLE 136. VIRTAMED: KEY DEVELOPMENTS
List of Figures
FIGURE 01. MEDICAL SIMULATION MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTES
FIGURE 09. MODERATE THREAT OF NEW ENTRANTS
FIGURE 10. HIGH INTENSITY OF RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. COMPARATIVE ANALYSIS OF MODEL-BASED SIMULATION MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 14. COMPARATIVE ANALYSIS OF WEB-BASED SIMULATION MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 15. COMPARATIVE ANALYSIS OF SIMULATION TRAINING SERVICES MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 16. COMPARATIVE ANALYSIS OF LOW FIDELITY, BY COUNTRY, 2020-2030 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF MEDIUM-FIDELITY, BY COUNTRY, 2020-2030 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF HIGH FIDELITY, BY COUNTRY, 2020-2030 (%)
FIGURE 19. COMPARATIVE ANALYSIS OF MEDICAL SIMULATION MARKET FOR ACADEMIC INSTITUTIONS, BY COUNTRY, 2020-2030 (%)
FIGURE 20. COMPARATIVE ANALYSIS OF MEDICAL SIMULATION MARKET FOR HOSPITALS, BY COUNTRY, 2020-2030 (%)
FIGURE 21. COMPARATIVE ANALYSIS OF MEDICAL SIMULATION MARKET FOR MILITARY ORGANIZATIONS, BY COUNTRY, 2020-2030 (%)
FIGURE 22. CAE: NET SALES, 2018–2020 ($MILLION)
FIGURE 23. CAE: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 24. CAE: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 25. INTELLIGENT: NET SALES, 2018–2020 ($MILLION)
FIGURE 26. INTELLIGENT: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 27. INTELLIGENT: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 28. MENTICE: NET SALES, 2018–2020 ($MILLION)
FIGURE 29. MENTICE: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 30. MENTICE: REVENUE SHARE, BY REGION, 2020 (%)

Companies Mentioned

  • CAE Inc.
  • Gaumard Scientific Company Inc.
  • Intelligent Ultrasound Group Plc.
  • Kyoto Kagaku Co. Ltd.
  • Laerdal Medical AS
  • Limbs
  • Things Ltd.
  • Mentice AB
  • Operative Experience Inc.
  • Simulab Corporation
  • VirtaMed AG

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information